<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 6 Issue 3</issue_number>
<issue_period>2015 (July - September)</issue_period>
<title>ENTEROBACTER SAKAZAKII BE INHIBITED BY TRIGONA SPP. PROPOLIS FROM PANDEGLANG INDONESIA </title>
<abstract>Propolis has many advantages and specific potencies, due to its properties as antibacterial, antivirus, and anticancer. Aim of the study is to determine the propolis potency of  lessThan i greaterThan Trigona  lessThan /i greaterThan spp as antibacterial agent against lessThan i greaterThan  E. sakazakii lessThan /i greaterThan . The antibacterial activity test was performed by a modified agar well diffusion against three isolates of bacteria  lessThan i greaterThan E. sakazakii lessThan /i greaterThan  IB-19b, IB-29a, and ATCC 35217. Through the initiation test, propolis activity was higher than commercial propolis, and lower than ampicillin. The effect of propolis extract to commercial propolis for each isolate IB-19b, IB -29a, and ATCC 35217 were 143.99%, 169.65%, and 155.76% respectively. The effects of propolis extract to ampicillin for each isolate IB-19b, IB-29a, and ATCC 35217 were 39.37%, 38.94%, and 47.37% respectively. The minimum inhibition concentration (MIC) differed for each isolate, the minimum inhibition concentration for IB-19b, IB-29a, and ATCC 35217 were 12.50%, 25.00%, and 50.00% respectively.</abstract>
<authors>A.E.Z. HASAN, SURYANI, S. ESTUNINGSIH  AND FITRIANNUR</authors>
<keywords>propolis, antibacterial, Enterobacter sakazakii, Trigona spp, Indonesia</keywords>
<pages>420-428</pages>
</article>
</Journal>
